Logo image of 1SXP.DE

SCHOTT PHARMA AG& CO KGAA (1SXP.DE) Stock Price, Forecast & Analysis

Europe - Frankfurt Stock Exchange - FRA:1SXP - DE000A3ENQ51 - Common Stock

18.93 EUR
-0.07 (-0.37%)
Last: 11/27/2025, 5:29:15 PM

1SXP.DE Key Statistics, Chart & Performance

Key Statistics
Market Cap2.85B
Revenue(TTM)975.68M
Net Income(TTM)147.00M
Shares150.61M
Float34.64M
52 Week High30.25
52 Week Low17.9
Yearly Dividend0.15
Dividend Yield0.87%
EPS(TTM)0.97
PE19.52
Fwd PE16.18
Earnings (Next)12-11 2025-12-11
IPO2023-09-28
Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences


1SXP.DE short term performance overview.The bars show the price performance of 1SXP.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -10 -20 -30

1SXP.DE long term performance overview.The bars show the price performance of 1SXP.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30

The current stock price of 1SXP.DE is 18.93 EUR. In the past month the price decreased by -2.42%. In the past year, price decreased by -31.41%.

SCHOTT PHARMA AG& CO KGAA / 1SXP Daily stock chart

1SXP.DE Competitors/Peers

The largest stocks on the EU markets in the "Life Sciences Tools & Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
DIM.PA SARTORIUS STEDIM BIOTECH 47.1 19.76B
56S1.DE SARTORIUS STEDIM BIOTECH 46.57 19.53B
SRT3.DE SARTORIUS AG-VORZUG 53.73 18.35B
SRT.DE SARTORIUS AG 41.89 14.30B
QIA.DE QIAGEN N.V. 20.22 8.99B
EVT.DE EVOTEC SE N/A 2.07B
GXI.DE GERRESHEIMER AG 6.83 871.10M
FF.MI FINE FOODS & PHARMACEUTICALS 10.79 211.78M

About 1SXP.DE

Company Profile

1SXP logo image SCHOTT Pharma AG & Co. KgaA engages in the provision of designing drug containment and drug delivery solutions. The company is headquartered in Mainz, Hessen and currently employs 4,689 full-time employees. The company went IPO on 2023-09-28. The firm is primarily engaged in designing advanced drug containment solutions and drug delivery systems for the pharmaceutical and biotech industries. The Company’s portfolio ranges from syringes and cartridges to vials and ampoules, all made using Type I Borosilicate Glass and high-grade pharmaceutical polymer.

Company Info

SCHOTT PHARMA AG& CO KGAA

Hattenbergstrasse 10

MAINZ HESSEN DE

Employees: 4689

1SXP Company Website

1SXP Investor Relations

Phone: 496131660

SCHOTT PHARMA AG& CO KGAA / 1SXP.DE FAQ

Can you describe the business of SCHOTT PHARMA AG& CO KGAA?

SCHOTT Pharma AG & Co. KgaA engages in the provision of designing drug containment and drug delivery solutions. The company is headquartered in Mainz, Hessen and currently employs 4,689 full-time employees. The company went IPO on 2023-09-28. The firm is primarily engaged in designing advanced drug containment solutions and drug delivery systems for the pharmaceutical and biotech industries. The Company’s portfolio ranges from syringes and cartridges to vials and ampoules, all made using Type I Borosilicate Glass and high-grade pharmaceutical polymer.


What is the stock price of SCHOTT PHARMA AG& CO KGAA today?

The current stock price of 1SXP.DE is 18.93 EUR. The price decreased by -0.37% in the last trading session.


What is the dividend status of SCHOTT PHARMA AG& CO KGAA?

SCHOTT PHARMA AG& CO KGAA (1SXP.DE) has a dividend yield of 0.87%. The yearly dividend amount is currently 0.15.


How is the ChartMill rating for SCHOTT PHARMA AG& CO KGAA?

1SXP.DE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 6 out of 10.


How is the market expecting 1SXP stock to perform?

19 analysts have analysed 1SXP.DE and the average price target is 29.58 EUR. This implies a price increase of 56.26% is expected in the next year compared to the current price of 18.93.


Can you provide the upcoming earnings date for SCHOTT PHARMA AG& CO KGAA?

SCHOTT PHARMA AG& CO KGAA (1SXP.DE) will report earnings on 2025-12-11.


1SXP.DE Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

1SXP.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to 1SXP.DE. 1SXP.DE scores excellent on profitability, but there are some minor concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

1SXP.DE Financial Highlights

Over the last trailing twelve months 1SXP.DE reported a non-GAAP Earnings per Share(EPS) of 0.97. The EPS decreased by -3% compared to the year before.


Industry RankSector Rank
PM (TTM) 15.07%
ROA 9.62%
ROE 17.03%
Debt/Equity 0.09
Chartmill High Growth Momentum
EPS Q2Q%-3.23%
Sales Q2Q%1.13%
EPS 1Y (TTM)-3%
Revenue 1Y (TTM)2.86%

1SXP.DE Forecast & Estimates

19 analysts have analysed 1SXP.DE and the average price target is 29.58 EUR. This implies a price increase of 56.26% is expected in the next year compared to the current price of 18.93.

For the next year, analysts expect an EPS growth of 3.25% and a revenue growth 2.31% for 1SXP.DE


Analysts
Analysts78.95
Price Target29.58 (56.26%)
EPS Next Y3.25%
Revenue Next Year2.31%

1SXP.DE Ownership

Ownership
Inst Owners19.52%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A